before few years, the UK has witnessed a revolution in clinical pounds‑loss solutions — through the introduction of semaglutide (Wegovy®) for the increasing reputation of tirzepatide (Mounjaro®). Now, Yet another name is drawing consideration in both of those scientific and community health circl